Table 1

Baseline demographics by HIV status

VariablesHIV-negativeHIV-positiveP value
N=358N=104
Age, Mean (SD)54.204 (14.754)52.462 (10.760)0.263
Gender, N (%)0.196
 Male97 (27.1%)21 (20.2%)
 Female261 (72.9%)83 (79.8%)
BMI, Mean (SD)33.248 (11.186)32.797 (11.123)0.717
Asthma severity, N %
 Intermittent asthma15 (4.1%)12 (11.5%)0.008
 Mild persistent asthma69 (19.2%)26 (25%)0.216
 Moderate persistent asthma178 (49.7)52 (50%)1.000
 Severe persistent asthma96 (26.8%)14 (13.4%)0.004
FEV169.39 (18.05) N=14664.58 (17.88) N=290.86
FEV1/FVC72.22 (13.48) N=14677.13 (14.82) N=290.08
Smoker (%)139/35950/1040.08
Comorbid conditions, N (%)
 CHF60 (16.8%)7 (6.7%)0.016
 Atrial fibrillation25 (7%)10 (9.6%)0.495
 Pulmonary embolism17 (4.7%)4 (3.8%)0.903
 Renal failure15 (4.2%)10 (9.6%)0.057
 Liver cirrhosis1 (0.3%)0 (0%)1.000
Inhaled corticosteroid use, N (%)343 (95.8%)92 (88.4%)0.6287
Short acting beta-agonist use, N%353 (98.6%)102 (98%)0.658
Laboratory valuesMean (SD)Mean (SD)
 pCO2, serum (mm Hg)40.69 (7.29) n=14042.84 (5.6) n=450.07
 pH, serum7.384 (0.049) n=1407.385 (0.067) n=450.9
 Bicarbonate, serum (mEq/L)25.816 (3.526)25.632 (3.877)0.658
 Creatinine, serum (mg/dL)0.813 (0.509)1.117 (1.390)<0.001
 Albumin, serum (g/dL)3.940 (0.443)3.754 (0.480)0.003
 WBC, serum (k/uL)9.92 (3.67)8.13 (3.38)0.001
 Eosinophils, serum (cells/μL)243.70 (338.66)492.91 (1789.09)0.013
 Neutrophis, serum (k/μL)7.194 (3.59)5.74 (3.18)0.0002
 IgE, serum(kU/L)425 (525.58) n=73337.57 (516.267) n=140.57
N (%)N (%)
Troponinemia, serum8/176 (4.3%)1/35 (2.9%)1.000
  • BMI, body mass index; CHF, congestive heart failure; g/dL, grams per decilitre;k/μL, thousands per cubic millilitre; kU/L, thousand units per litre; mEq/L, milliequivalents per litre; mg/dL, milligrams per decilitre; mm Hg, millimetres of mercury; WBC, white blood cell count.